Mereo BioPharma Group (MREO)
NASDAQ: MREO
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 07:50 PM EDT
Mereo BioPharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 62.48M | 69.8M | 80.52M | 87.43M | 48.66M | 57.42M | 47.07M | 42.11M | n/a | 56.33M | 61.06M | 76.42M | 94.3M | 110.09M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51.1M | 51.1M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | -68.18M | -25.95M | -24.12M | -26.23M | n/a | n/a |
Receivables | 2.4M | 3.25M | 2.84M | 2.67M | 2.15M | 3.73M | n/a | 10.74M | n/a | 2.38M | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | 1.82M | 1.25M | n/a | -2.85M | n/a | -2.38M | n/a | n/a | n/a | n/a |
Other Current Assets | 851K | 507K | 464K | 2.63M | 864K | 1.36M | 3.56M | 4.22M | n/a | 1.43M | 2.9M | 2.65M | 2.23M | 5.82M |
Total Current Assets | 66.9M | 74.76M | 86.72M | 93.94M | 53.5M | 63.76M | 52.26M | 54.23M | 68.18M | 62.13M | 67.34M | 81.81M | 99.32M | 120.33M |
Property-Plant & Equipment | 869K | 984K | 1.22M | 1.32M | 1.47M | 1.65M | 1.35M | 1.56M | n/a | 1.83M | 1.98M | 2.11M | 2.53M | 2.39M |
Goodwill & Intangibles | 554K | 643K | 799K | 866K | 972K | 1.09M | 892.61K | 24.84M | n/a | 24.12M | 24.12M | 24.12M | 24.56M | 22.19M |
Total Long-Term Assets | 1.42M | 1.63M | 2.02M | 2.19M | 2.44M | 2.74M | 2.25M | 26.41M | -68.18M | 25.95M | 1.98M | 26.23M | 27.09M | 24.58M |
Total Assets | 68.32M | 76.39M | 88.75M | 96.13M | 55.94M | 66.5M | 54.51M | 80.64M | n/a | 88.08M | 69.32M | 108.04M | 126.42M | 144.92M |
Account Payables | 2.92M | 2.44M | 1.75M | 2.7M | 2.46M | 2.35M | 1.92M | 1.91M | n/a | 3.49M | 3.13M | 2.82M | 2.29M | 2.19M |
Deferred Revenue | n/a | n/a | 2.51M | n/a | 3.22M | 6.46M | n/a | 9.49M | n/a | n/a | n/a | n/a | 8.37M | 5.46M |
Short-Term Debt | n/a | 5.54M | 5.55M | 4.93M | 3.67M | 652K | n/a | 4.19M | n/a | 11.02M | 11.93M | 15.95M | n/a | n/a |
Other Current Liabilities | 988K | 2.36M | 4.56M | 6.04M | 1.72M | 89K | 607.37K | 10.64M | n/a | 5.82M | 1.21M | 18.26M | 5.62M | 6.55M |
Total Current Liabilities | 7.5M | 13.85M | 14.21M | 15.47M | 11M | 9.49M | 7.78M | 17.46M | n/a | 24.68M | 21.83M | 35.21M | 12.54M | 9.87M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 4.39M | 3.6M | 3.67M | n/a | n/a | n/a | n/a | 14.38M | 17.93M |
Other Long-Term Liabilities | 744K | 1.39M | 1.61M | 1.46M | 1.37M | 1.18M | 963.92K | 2.21M | -51.4M | 54K | 140.59K | 2.48M | 21.66M | 55.36M |
Total Long-Term Liabilities | 744K | 1.57M | 2M | 2.01M | 2.1M | 6.48M | 5.31M | 5.43M | -51.4M | 1.53M | 1.47M | 3.24M | 25.87M | 54.36M |
Total Liabilities | 8.24M | 15.42M | 16.21M | 17.48M | 13.1M | 15.96M | 13.08M | 22.89M | -51.4M | 26.21M | 23.29M | 38.45M | 38.41M | 64.24M |
Total Debt | 747K | 6.43M | 6.68M | 6.16M | 6.02M | 5.95M | 4.34M | 9.31M | n/a | 12.77M | 13.26M | 17.99M | 16.76M | 20.61M |
Common Stock | 3.13M | 3.06M | 3.05M | 3.03M | 2.77M | 2.77M | 2.27M | 1.93M | n/a | 1.88M | 2.22M | 1.75M | 1.75M | 1.63M |
Retained Earnings | -472.03M | -462.88M | -455.84M | -440.84M | -428.58M | -419.63M | -343.95M | -342.19M | n/a | -331.16M | -362.29M | -316.13M | -296.97M | -297.61M |
Comprehensive Income | -15.29M | -18.85M | -11.1M | -18.28M | -18.28M | -17.48M | -14.33M | 141.72M | 51.4M | 137.91M | -19.42M | 137.55M | 136.9M | 81.15M |
Shareholders Equity | 60.08M | 60.97M | 72.54M | 78.65M | 42.84M | 50.54M | 41.42M | 57.74M | 51.4M | 61.87M | 46.03M | 69.58M | 88M | 80.68M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51.1M | 51.1M | n/a | n/a | n/a |